Results 171 to 180 of about 18,578 (279)

Agglutinins and Incomplete Antibodies after a Single Antigenic Inoculation in Normal and Rheumatic Individuals

open access: green, 1955
Verena Wagner   +5 more
openalex   +1 more source

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 17, July 4, 2025.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray   +2 more
wiley   +1 more source

Protein‐Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial Infarction

open access: yesAdvanced Materials, Volume 37, Issue 27, July 10, 2025.
We describe a Keap1 targeting protein‐like polymer (PLP) which activates Nrf2, an important cytoprotective transcription factor for relieving myocardial infarction‐induced oxidative stress. This PLP increases cell survival in vitro in multiple relevant cardiac cell types and elicits pro‐reparative responses, improving cardiac function in a preclinical ...
Joshua M. Mesfin   +17 more
wiley   +1 more source

Risk Factors Associated with the Seroprevalence of Leptospirosis in Small Ruminants from a Semi-Arid Region of Mexico. [PDF]

open access: yesPathogens
Chávez-Sánchez JF   +7 more
europepmc   +1 more source

The FGF13‐Caveolin‐1 Axis: A Key Player in the Pathogenesis of Doxorubicin‐ and D‐Galactose‐Induced Premature Cardiac Aging

open access: yesAdvanced Science, Volume 12, Issue 25, July 3, 2025.
The FGF13 level is significantly downregulated in premature aging murine hearts subject to D‐galactose and Doxorubicin. FGF13 overexpression and deficiency exacerbated and alleviated Doxorubicin/D‐galactose‐induced myocardial aging characteristics and functional impairment, respectively.
Enzhao Shen   +15 more
wiley   +1 more source

Immune hemolytic anemia associated with the use of immune checkpoint inhibitors: a scoping review. [PDF]

open access: yesFront Immunol
Hernandez-Martinez JM   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy